Original
Predictors of Tumor Response to Cetuximab and Panitumumab in 116 Patients and a Review of Approaches to Managing Skin Toxicity
Factores predictores de respuesta y revisión de la toxicidad cutánea de cetuximab y panitumumab en 116 pacientes
A. Jakaa,
, A. Gutiérrez-Riverab, A. López-Pestañaa, E. del Alcázara, J. Zubizarretaa, S. Vildosolaa, M.A. Arreguia, C. Sarasquetad, C. Loboc, A. Tuneua
Autor para correspondencia
a Servicio de Dermatología. Hospital Universitario Donostia, San Sebastián, Spain
b Laboratorio de Ingeniería tisular, Instituto Biodonostia, Hospital Universitario Donostia, San Sebastián, Spain
c Servicio de Anatomía Patológica, Hospital Universitario Donostia, San Sebastián, Spain
d Unidad de Metodología, Instituto Biodonostia, Hospital Universitario Donostia, San Sebastián, Spain
Leído
11235
Vecesse ha leído el artículo
3606
Total PDF
7629
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 155 | 10 | 165 |
| 2025 5 | 387 | 50 | 437 |
| 2025 4 | 427 | 41 | 468 |
| 2025 3 | 347 | 48 | 395 |
| 2025 2 | 324 | 46 | 370 |
| 2025 1 | 200 | 47 | 247 |
| 2024 12 | 173 | 38 | 211 |
| 2024 11 | 159 | 72 | 231 |
| 2024 10 | 164 | 64 | 228 |
| 2024 9 | 144 | 56 | 200 |
| 2024 8 | 139 | 84 | 223 |
| 2024 7 | 125 | 53 | 178 |
| 2024 6 | 110 | 58 | 168 |
| 2024 5 | 112 | 50 | 162 |
| 2024 4 | 120 | 32 | 152 |
| 2024 3 | 106 | 34 | 140 |
| 2024 2 | 126 | 60 | 186 |
| 2024 1 | 106 | 50 | 156 |
| 2023 12 | 98 | 41 | 139 |
| 2023 11 | 127 | 68 | 195 |
| 2023 10 | 131 | 54 | 185 |
| 2023 9 | 161 | 61 | 222 |
| 2023 8 | 88 | 42 | 130 |
| 2023 7 | 90 | 82 | 172 |
| 2023 6 | 94 | 59 | 153 |
| 2023 5 | 123 | 79 | 202 |
| 2023 4 | 100 | 58 | 158 |
| 2023 3 | 81 | 54 | 135 |
| 2023 2 | 67 | 52 | 119 |
| 2022 1 | 59 | 52 | 111 |
| 2022 12 | 79 | 59 | 138 |
| 2022 11 | 45 | 51 | 96 |
| 2022 10 | 33 | 34 | 67 |
| 2022 9 | 34 | 52 | 86 |
| 2022 8 | 26 | 33 | 59 |
| 2022 7 | 29 | 34 | 63 |
| 2022 6 | 38 | 48 | 86 |
| 2022 5 | 109 | 50 | 159 |
| 2022 4 | 108 | 51 | 159 |
| 2022 3 | 82 | 82 | 164 |
| 2022 2 | 136 | 44 | 180 |
| 2021 1 | 114 | 53 | 167 |
| 2021 12 | 104 | 47 | 151 |
| 2021 11 | 125 | 57 | 182 |
| 2021 10 | 102 | 69 | 171 |
| 2021 9 | 81 | 44 | 125 |
| 2021 8 | 98 | 34 | 132 |
| 2021 7 | 81 | 59 | 140 |
| 2021 6 | 93 | 61 | 154 |
| 2021 5 | 66 | 62 | 128 |
| 2021 4 | 107 | 94 | 201 |
| 2021 3 | 90 | 31 | 121 |
| 2021 2 | 90 | 26 | 116 |
| 2020 1 | 66 | 20 | 86 |
| 2020 12 | 45 | 24 | 69 |
| 2020 11 | 32 | 21 | 53 |
| 2020 10 | 20 | 16 | 36 |
| 2020 9 | 30 | 22 | 52 |
| 2020 8 | 39 | 24 | 63 |
| 2020 7 | 29 | 24 | 53 |
| 2020 6 | 51 | 34 | 85 |
| 2020 5 | 36 | 36 | 72 |
| 2020 4 | 37 | 25 | 62 |
| 2020 3 | 63 | 27 | 90 |
| 2020 2 | 5 | 3 | 8 |
| 2020 1 | 4 | 2 | 6 |
| 2019 12 | 4 | 5 | 9 |
| 2019 11 | 0 | 2 | 2 |
| 2019 10 | 0 | 1 | 1 |
| 2019 9 | 10 | 4 | 14 |
| 2019 8 | 0 | 1 | 1 |
| 2019 7 | 0 | 11 | 11 |
| 2019 6 | 0 | 13 | 13 |
| 2019 5 | 5 | 24 | 29 |
| 2019 4 | 12 | 2 | 14 |
| 2019 3 | 3 | 3 | 6 |
| 2019 2 | 2 | 0 | 2 |
| 2019 1 | 2 | 2 | 4 |
| 2018 11 | 2 | 0 | 2 |
| 2018 10 | 2 | 0 | 2 |
| 2018 9 | 3 | 0 | 3 |
| 2018 8 | 0 | 5 | 5 |
| 2018 7 | 0 | 1 | 1 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 0 | 9 | 9 |
| 2018 4 | 0 | 2 | 2 |
| 2018 3 | 3 | 5 | 8 |
| 2018 2 | 26 | 12 | 38 |
| 2018 1 | 44 | 18 | 62 |
| 2017 12 | 43 | 12 | 55 |
| 2017 11 | 29 | 16 | 45 |
| 2017 10 | 39 | 18 | 57 |
| 2017 9 | 32 | 21 | 53 |
| 2017 8 | 33 | 14 | 47 |
| 2017 7 | 36 | 18 | 54 |
| 2017 6 | 37 | 33 | 70 |
| 2017 5 | 30 | 28 | 58 |
| 2017 4 | 35 | 24 | 59 |
| 2017 3 | 27 | 29 | 56 |
| 2017 2 | 36 | 16 | 52 |
| 2016 1 | 21 | 16 | 37 |
| 2016 12 | 24 | 13 | 37 |
| 2016 11 | 41 | 19 | 60 |
| 2016 10 | 32 | 52 | 84 |
| 2016 9 | 0 | 5 | 5 |
| 2016 8 | 0 | 3 | 3 |
| 2016 7 | 8 | 5 | 13 |
| 2016 6 | 11 | 2 | 13 |
| 2016 5 | 5 | 12 | 17 |
| 2016 4 | 3 | 9 | 12 |
| 2016 3 | 3 | 10 | 13 |
| 2016 2 | 6 | 14 | 20 |
| 2015 1 | 8 | 5 | 13 |
| 2015 12 | 1 | 4 | 5 |
| 2015 11 | 0 | 7 | 7 |
| 2015 10 | 0 | 8 | 8 |
| 2015 9 | 0 | 9 | 9 |
| 2015 8 | 0 | 14 | 14 |
| 2015 7 | 1 | 1 | 2 |
Mostrar todo
